Miller Steve — SEC Form 4 filings

SEC reporting owner CIK 1402535. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CATALYST PHARMACEUTICALS, INC. (CPRX)Chief Op. & Scientific Officer125 legs · 315,000 sh · $6,481,45037

Form 4 filings — Miller Steve

FiledFormIssuerReported transactionsSource
2026-07-174CATALYST PHARMACEUTICALS, INC. (CPRX)Disposition to issuer (D): 1,093,803 @ $31.50 · Disposition to issuer (D): 180,000 (derivative) @ $0 · Disposition to issuer (D): 275,000 (derivative) @ $0 · Disposition to issuer (D): 185,000 (derivative) @ $0 · Disposition to issuer (D): 146,000 (derivative) @ $0 · Disposition to issuer (D): 248,004 (derivative) @ $0 · +5 moreEDGAR
2025-12-304CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 14,000 · Option exercise (M): 14,000 (derivative) @ $0EDGAR
2025-12-104CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 11,873 · Option exercise (M): 11,873 (derivative) @ $0EDGAR
2025-11-244CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 8,267 · Grant/award (A): 158,454 (derivative) @ $0 · Grant/award (A): 47,826 (derivative) @ $0 · Option exercise (M): 8,267 (derivative) @ $0EDGAR
2025-08-284CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 115,000 @ $2.24 · Sale (S): 115,000 @ $20.28 · Option exercise (M): 110,000 @ $2.24 · Option exercise (M): 115,000 (derivative) @ $0 · Option exercise (M): 110,000 (derivative) @ $0EDGAR
2025-02-194CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 13,667 · Option exercise (M): 13,667 (derivative) @ $0EDGAR
2024-12-314CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 14,000 · Option exercise (M): 14,000 (derivative) @ $0EDGAR
2024-12-174CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 235,000 @ $4.01 · Option exercise (M): 235,000 (derivative) @ $0EDGAR
2024-12-114CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 11,872 · Option exercise (M): 50,000 @ $4.01 · Sale (S): 50,000 @ $21.93 · Option exercise (M): 11,872 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2024-11-254CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 202,958 (derivative) @ $0 · Grant/award (A): 24,801 (derivative) @ $0EDGAR
2024-08-224CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 50,000 @ $20.26 · Sale (S): 50,000 @ $20.21 · Sale (S): 50,000 @ $20.59EDGAR
2024-02-164CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 13,667 · Option exercise (M): 13,667 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1402535 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →